Irinotecan
CAS No. 97682-44-5
Irinotecan ( —— )
Catalog No. M16884 CAS No. 97682-44-5
Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 38 | In Stock |
|
50MG | 53 | In Stock |
|
100MG | 82 | In Stock |
|
500MG | 206 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIrinotecan
-
NoteResearch use only, not for human use.
-
Brief DescriptionIrinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.
-
DescriptionIrinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorTopo I
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number97682-44-5
-
Formula Weight586.68
-
Molecular FormulaC33H38N4O6
-
Purity>98%(HPLC)
-
SolubilityDMSO: 7 mg/mL (11.93 mM)
-
SMILESCCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pavillard V, et al. Y ChemOthers Pharmacol. 2002, 49(4), 329-335.
molnova catalog
related products
-
9-Methoxycamptotheci...
9-Methoxycamptothecin (MCPT) has antitumour activities through topoisomerase inhibition.
-
SN-38
LE-SN38 is NeoPharm’s NeoLipid liposomal formulation of SN-38, the active metabolite of irinotecan (Camptosar), a chemotherapeutic pro-drug approved for the treatment of advanced colorectal Y.
-
Pirarubicin
Pirarubicin is an anthracycline antibiotic, and also a DNA/RNA synthesis inhibitor by intercalating into Dna and interacts with topoisomerase II, used as an antineoplastic agent.